Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Orphanet Journal of Rare Diseases|June 17, 2015
Quality of life in patients with Fabry disease: a systematic review of the literatureMaarten Arends, Carla E M Hollak, Marieke Biegstraaten
Molecular Genetics and Metabolism|December 15, 2015
Discontinuation of enzyme replacement therapy in Fabry disease in the Dutch cohortMaarten Arends, Gabor E Linthorst, Carla E Hollak, et al.
British Journal of Haematology|April 19, 2013
Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literatureMaarten Arends, Laura van Dussen, Marieke Biegstraaten, et al.
Orphanet Journal of Rare Diseases|July 25, 2014
Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complicationsLaura van Dussen, Marieke Biegstraaten, Marcel Gw Dijkgraaf, et al.
Current Pain and Headache Reports|September 3, 2013
Fabry disease: a rare cause of neuropathic painMarieke Biegstraaten, Gabor E Linthorst, Ivo N van Schaik, et al.
Orphanet Journal of Rare Diseases|April 16, 2014
Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher diseaseLaura van Dussen, Marieke Biegstraaten, Carla E M Hollak, et al.
The British Journal of Ophthalmology|February 14, 2015
Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic reviewLinda van der Tol, Marije L Sminia, Carla E M Hollak, et al.
Journal of Inherited Metabolic Disease|October 18, 2017
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort studyMaarten Arends, Simon Körver, Derralynn A Hughes, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 17, 2010
Poikilothermia in a 38-year-old Fabry patientMarieke Biegstraaten, Ivo N van Schaik, Carla E M Hollak, et al.
Pageof 3